Mechanisms of Yiai Fuzheng formula in the treatment of triple-negative breast cancer based on UPLC-Q-Orbitrap-HRMS, network pharmacology, and experimental validation
Author:
Li RuijieORCID,
Ke Haoliang,
Liu Pan,
Yang Qian,
Li Yuxin,
Ke Longzhu,
Wang Xiuping,
Wu Chaoyan,
Zhang Yingwen